CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia
NCT00272584
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Psychosis, Schizophrenia
Interventions
DRUG:
Risperidone
Sponsor
University of British Columbia